The current prices are delayed, login to your account for live prices
LOGIN
Create Alert
Watchlist

Mankind Pharma

2581.60
+61.60 (2.44%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Overview
News
Events

Performance

Open
2,509.90
Prev. Close
2,520.00
Volume
4,89,420
Total traded value
126 Cr
Upper Circuit
3,024.00
Lower Circuit
2,016.00

Market Depth

Buy order quantity
Sell order quantity
0.00%
75.07%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Ask Price
Qty
2,581.60
1
0.00
0
0.00
0
0.00
0
0.00
0
Ask Total
1

Analyst Estimates

45%
Buy
45%
Hold
36%
Sell
18%
Aggregated by Refinitiv from 11 Analysts

Fundamentals

Market Cap₹1,04,071Cr
ROE20.02%
P/E Ratio(TTM)50.98
EPS(TTM)49.48
P/B Ratio7.67
Dividend Yield0.00%
Industry P/E33.61
Book Value328.78
Debt to Equity0.05
Face Value1
Understand Fundamentals

Financials

Revenue
Profit
Net Worth
*All values are in Rs. Cr
2,6772,5332,9943,1863,307Dec '23Mar '24Jun '24Sep '24Dec '24
Quarterly
Yearly

About Mankind Pharma

Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.;
Parent OrganisationMankind Pharma
Managing DirectorMr. Rajeev Juneja
NSE SymbolMANKIND

Shareholding Pattern

Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Promoters
72.71%
Foreign Institutions
13.34%
Mutual Funds
7.83%
Other Domestic Institutions
3.23%
Retail And Others
2.90%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
35.52
Cipla
NA
(0.00%)
24.22
Dr Reddy's Laboratories
NA
(0.00%)
18.01
Lupin
NA
(0.00%)
30.81
Groww
Want to invest in this stock?
Open a free Demat account in minutes to start investing in stocks.
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.9.4
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW